| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | 0.094 | 0.002 |
| mRNA | AKT inhibitor VIII | GDSC1000 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | ibrutinib | CTRPv2 | pan-cancer | AAC | 0.13 | 0.002 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | 0.15 | 0.003 |
| mRNA | GDC-0941 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.003 |
| mRNA | CI-1040 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.003 |
| mRNA | BRD-K51490254 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.003 |
| mRNA | NVP-BSK805 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.003 |
| mRNA | AZD0530 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.004 |
| mRNA | PF-562271 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.004 |